Management of Obesity and Cardiometabolic Risk &Ndash; Role of Phentermine/Extended Release Topiramate

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - New Zealand
doi 10.2147/dmso.s38979
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2011English

Pharmacokinetic Simulations of Topiramate Plasma Concentrations Following Dosing Irregularities With Extended-Release vs. Immediate-Release Formulations

Epilepsy and Behavior
NeurologyBehavioral Neuroscience
2015English

Combination Phentermine and Topiramate for Weight Maintenance: The First Australian Experience

Medical Journal of Australia
Medicine
2014English

Adolescent Obesity, Bone Mass, and Cardiometabolic Risk Factors

Journal of Pediatrics
Child HealthPediatricsPerinatology
2011English

Childhood Obesity, Bone Development, and Cardiometabolic Risk Factors

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2015English

Visceral Obesity and Cardiometabolic Risk: Features of Hormonal and Immune Regulation

Obesity and Metabolism
Internal MedicineNutritionEndocrinologyPublic HealthEnvironmentalDieteticsOccupational HealthMetabolismDiabetes
2017English

Topiramate Extended-Release Options: A Focus on Efficacy and Safety in Epilepsy and Comorbidities

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2017English

Effect of Adolescent Obesity on Cardiometabolic Risk in African-Americans and Caucasians

ISRN Obesity
2012English

Plant Oils and Cardiometabolic Risk Factors: The Role of Genetics

Current Nutrition Reports
NutritionFood ScienceDietetics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy